Abstract:OBJECTIVE:To explore the natural mutations in Spike protein (S protein) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the changes of affinity between virus and associated receptors or drug molecules before and after the mutation based on whole length sequencing results.METHODS:In the study, the bioinformatics analysis of all the published sequences of SARS-CoV-2 was conducted and thus the high frequency mutation sites were affirmed. Taking advantages of PolyPhen-2, the functional influence of each mutation in S protein was prospected. The 3D homologous modelling was performed by SWISS-MODEL to establish mutated S protein structural model, in which the protein-docking was then implemented with angiotensin-converting enzyme 2 (ACE2), dipeptidyl peptidase-4 (DPP4) and aminopeptidase N (APN) by ZDOCK, and the combining capacity of each mutated S protein evaluated by FiPD. Finally, the binding ability between mutated S proteins and anti-virus drugs were prospected and evaluated through AutoDock-Chimera 1.14.RESULTS:The mutations in specific region of S protein had greater tendency to destroy the S protein function by analysis of mutated S protein structure. Protein-receptor docking analysis between naturally mutated S protein and host receptors showed that, in the case of spontaneous mutation, the binding ability of S protein to ACE2 tended to be weakened, while the binding ability of DPP4 tended to be enhanced, and there was no significant change in the binding ability of APN. According to the computational simulation results of affinity binding between small molecular drugs and S protein, the affinity of aplaviroc with S protein was significantly higher than that of other small molecule drug candidates.CONCLUSION:The region from 400-1 100 amino acid in S protein of SARS-CoV-2 is the mutation sensitive part during natural state, which was more potential to mutate than other part in S protein during natural state. The mutated SARS-CoV-2 might tend to target human cells with DPP4 as a new receptor rather than keep ACE2 as its unique receptor for human infection. At the same time, aplaviroc, which was used for the treatment of human immunodeficiency virus (HIV) infection, may become a new promising treatment for SARS-CoV-2 and could be a potential choice for the development of SARS-CoV-2 drugs.

Insight into molecular characteristics of SARS-CoV-2 spike protein following D614G point mutation, a molecular dynamics study

The Impact of D614G Mutation of SARS-COV-2 on the Efficacy of Anti-viral Drugs: A Comparative Molecular Docking and Molecular Dynamics Study

The Challenge of Emerging SARS-CoV-2 Mutants to Vaccine Development

Structural stability predictions and molecular dynamics simulations of RBD and HR1 mutations associated with SARS-CoV-2 spike glycoprotein

Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant

Molecular Dynamics Studies on the Structural Characteristics for the Stability Prediction of SARS-CoV-2

The Influence of Single-Point Mutation D614G on the Binding Process Between Human Angiotensin-Converting Enzyme 2 and the SARS-CoV-2 Spike Protein-an Atomistic Simulation Study

Structural Insights into the Effect of Mutations in the Spike Protein of SARS-CoV-2 on the Binding with Human Furin Protein

SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity

The role of S477N mutation in the molecular behavior of SARS-CoV-2 spike protein: An in-silico perspective

The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity

Emerging mutations in spike and other structural proteins of SARS-CoV-2

Molecular Insights into the Adaptive Evolution of SARS-CoV-2 Spike Protein.

N439K Variant in Spike Protein Alter the Infection Efficiency and Antigenicity of SARS-CoV-2 Based on Molecular Dynamics Simulation

Computational modelling of potentially emerging SARS-CoV-2 spike protein RBDs mutations with higher binding affinity towards ACE2: A structural modelling study

Distinct shifts in site-specific glycosylation pattern of SARS-CoV-2 spike proteins associated with arising mutations in the D614G and Alpha variants

Co-Mutations and Possible Variation Tendency of the Spike RBD and Membrane Protein in SARS-CoV-2 by Machine Learning

SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity

Impact of Missense Mutations on Spike Protein Stability and Binding Affinity in the Omicron Variant

N-glycosylation profiles of the SARS-CoV-2 spike D614G mutant and its ancestral protein characterized by advanced mass spectrometry

[Homologous Modeling and Binding Ability Analysis of Spike Protein after Point Mutation of Severe Acute Respiratory Syndrome Coronavirus 2 to Receptor Proteins and Potential Antiviral Drugs].